Meet The Brayden Cole Hinck Foundation Fellow

in Cancer and Blood Disease Research at CHLA 

The federal government invests just 4% of its annual cancer research budget for pediatric cancer. This equates to less than $3 per child. Funding for studies, such as Dr. Goldberg’s research, would not be possible without the support of private foundations like The Brayden Cole Hinck Foundation.   

“Organizations like The Brayden Cole Hinck Foundation are extremely important for getting researchers and their ideas off the ground,” Dr. Goldberg explained.  “The initial funding, before a clinical trial, is really important. I wouldn’t be able to do this without the funding from The Brayden Cole Hinck Foundation.”  

We will update you on Dr. Goldberg’s progress in the months to come.

None of this would be possible without your support. From the bottom of our hearts, we thank you for helping make a difference in the lives of families battling pediatric cancer. 

We are thrilled to share that thanks to all your generous donations, we were able to fund a fellowship at Children’s Hospital Los Angeles (CHLA), with the goal of finding new cures for pediatric brain cancer. Dr. Aaron Goldberg has been appointed The Brayden Cole Hinck Foundation Fellow in Cancer and Blood Disease Research, where he is engaged in pediatric neuro-oncology research.  

Dr. Goldberg’s area of focus is using immunotherapy to treat children with high grade gliomas, which is the type of brain tumor Brayden had. The type of immunotherapy he’s researching is CAR T-cell therapy, which involves taking a blood sample and reprogramming immune cells to attack a specific protein in the tumor.